DISCOVER STUDY IN THE ARGENTINE POPULATION
Introduction: type 2 diabetes mellitus (T2DM) is a highly prevalent metabolic disease, which constitutes an important cardiovascular risk factor, in which patients are not only diagnosed late, but remain for prolonged times, with glycemic and other cardiovascular risk factors poorly controlled. Ther...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
Sello Editorial Lugones
2020-08-01
|
| Series: | Revista de la Sociedad Argentina de Diabetes |
| Subjects: | |
| Online Access: | https://www.revistasad.com/index.php/diabetes/article/view/243 |
| Summary: | Introduction: type 2 diabetes mellitus (T2DM) is a highly prevalent metabolic disease, which constitutes an important cardiovascular risk factor, in which patients are not only diagnosed late, but remain for prolonged times, with glycemic and other cardiovascular risk factors poorly controlled. There is a significant therapeutic inertia in the implementation of antidiabetic drugs in the second line of treatment.
Objectives: the main objective of the DISCOVER study was to provide real- world data to assess antidiabetic therapy and prospective clinical outcomes in patients with T2DM who initiate a second line pharmacological therapy for blood glucose reduction.
The secondary objective was to obtain data from Argentina on glycemic control, metabolic control, comorbidities, cardiovascular risk factors and the concomitant therapeutic approach compared to the global world. |
|---|---|
| ISSN: | 0325-5247 2346-9420 |